phenylalanine and valproic acid

phenylalanine has been researched along with valproic acid in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kang, YS; Terasaki, T; Tsuji, A1
Filosto, M; Galli, R; Mancuso, M; Murri, L; Pizzanelli, C; Siciliano, G1
Gynther, M; Isotalo, A; Laine, K; Leppänen, J; Malmioja, K; Peura, L; Rautio, J1
Avellone, G; Carafa, M; Carletti, F; De Caro, V; Ferrantelli, E; Giannola, LI; Rizzo, V; Sardo, P; Scaturro, AL; Schiera, G; Sutera, FM1
Jahan, K; Pillai, KK; Vohora, D1

Other Studies

5 other study(ies) available for phenylalanine and valproic acid

ArticleYear
Acidic drug transport in vivo through the blood-brain barrier. A role of the transport carrier for monocarboxylic acids.
    Journal of pharmacobio-dynamics, 1990, Volume: 13, Issue:2

    Topics: Acetates; Acetic Acid; Animals; Anti-Bacterial Agents; Blood-Brain Barrier; Brain Chemistry; Carotid Arteries; Choline; Hydrogen-Ion Concentration; Injections, Intra-Arterial; Lactams; Nicotinic Acids; Parasympatholytics; Phenylalanine; Propiophenones; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Salicylates; Salicylic Acid; Tritium; Valproic Acid

1990
Antimyoclonic effect of levetiracetam in MERRF syndrome.
    Journal of the neurological sciences, 2006, Apr-15, Volume: 243, Issue:1-2

    Topics: Activities of Daily Living; Anticonvulsants; Atrophy; Brain; Drug Therapy, Combination; Female; Genetic Predisposition to Disease; Humans; Levetiracetam; MERRF Syndrome; Middle Aged; Mitochondria; Muscle, Skeletal; Mutation; Myoclonus; Phenylalanine; Piracetam; Quality of Life; RNA, Transfer; Treatment Outcome; Ubiquinone; Valproic Acid

2006
Large amino acid transporter 1 (LAT1) prodrugs of valproic acid: new prodrug design ideas for central nervous system delivery.
    Molecular pharmaceutics, 2011, Oct-03, Volume: 8, Issue:5

    Topics: Algorithms; Animals; Biological Transport; Blood-Brain Barrier; Brain; Brain Diseases; Central Nervous System Agents; Drug Design; Drug Stability; Gas Chromatography-Mass Spectrometry; Infusions, Intra-Arterial; Isomerism; Large Neutral Amino Acid-Transporter 1; Male; Molecular Structure; Phenylalanine; Prodrugs; Rats; Spectrometry, Mass, Electrospray Ionization; Valproic Acid

2011
N-valproyl-L-phenylalanine as new potential antiepileptic drug: synthesis, characterization and in vitro studies on stability, toxicity and anticonvulsant efficacy.
    Medicinal chemistry (Shariqah (United Arab Emirates)), 2014, Volume: 11, Issue:1

    Topics: Animals; Anticonvulsants; Astrocytes; Biological Transport; Cell Membrane Permeability; Cell Survival; Drug Stability; Evoked Potentials; Hippocampus; Hydrogen-Ion Concentration; Hydrolysis; Male; Microtomy; Phenylalanine; Primary Cell Culture; Rats; Rats, Wistar; Tissue Culture Techniques; Valproic Acid

2014
Parachlorophenylalanine-induced 5-HT depletion alters behavioral and brain neurotransmitters levels in 6-Hz psychomotor seizure model in mice.
    Fundamental & clinical pharmacology, 2017, Volume: 31, Issue:4

    Topics: Animals; Brain; Disease Models, Animal; Electroshock; gamma-Aminobutyric Acid; Glutamine; Male; Mice; Neurotransmitter Agents; Phenylalanine; Psychomotor Agitation; Seizures; Serotonin; Valproic Acid

2017